Literature DB >> 24286413

Analysis of Graves' ophthalmopathy patients' tear protein spectrum.

Li-hong Jiang1, Rui-li Wei.   

Abstract

BACKGROUND: Graves' ophthalmopathy/orbitopathy (GO) patients often suffer ocular surface damages and tear fluid proteins play a significant role in maintaining healthy ocular surfaces, while changes in tear protein components reflect the changes ocular surface abnormalities. In this study proteomics techniques were used to investigate tear protein compositions in GO patients.
METHODS: We carried out a case-control study by comparing tear fluid contents of GO patients with that of healthy subjects. In the first step the tears were subjected to SDS-PAGE electrophoresis and then single protein bands were analyzed by to in-gel trypsin digestion and nano-flow liquid mass spectrometry (LC-MS/MS) using a MS software.
RESULTS: In tear samples of GO subjects, the protein fractions of inflammation-related protein immunoglobulin kappa chain C region (IgKC) and serum albumin were essentially reduced, whereas a novel isoform of complement component 3 (C3), which we detected in control subjects, was completely absent in the GO patients' tears.
CONCLUSIONS: Reduced protein concentrations of particularly IgKC and complement C3 as well as albumin in the tears of GO patients may contribute to changes in their ocular surfaces via diminished reactive oxygen species (ROS) depletion and adaptive immune responses. The completely absent of C3 in the GO patients' tears, may imply that an important inflammatory signaling pathway is affected, which needs further investigation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24286413

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  5 in total

1.  Proteomics of Tear in Inactive Thyroid-Associated Ophthalmopathy.

Authors:  L Jiang; R Wei; J Diao; H Ding; W Wang; R Ao
Journal:  Acta Endocrinol (Buchar)       Date:  2021 Jul-Sep       Impact factor: 0.877

2.  A systematic review of multimodal clinical biomarkers in the management of thyroid eye disease.

Authors:  Stephanie Hiu Ling Poon; Janice Jing-Chee Cheung; Kendrick Co Shih; Yau Kei Chan
Journal:  Rev Endocr Metab Disord       Date:  2022-01-23       Impact factor: 6.514

3.  Combining micro-RNA and protein sequencing to detect robust biomarkers for Graves' disease and orbitopathy.

Authors:  Lei Zhang; Giulia Masetti; Giuseppe Colucci; Mario Salvi; Danila Covelli; Anja Eckstein; Ulrike Kaiser; Mohd Shazli Draman; Ilaria Muller; Marian Ludgate; Luigi Lucini; Filippo Biscarini
Journal:  Sci Rep       Date:  2018-05-30       Impact factor: 4.379

4.  Tear Proteins Calcium binding protein A4 (S100A4) and Prolactin Induced Protein (PIP) are Potential Biomarkers for Thyroid Eye Disease.

Authors:  Chiaw-Ling Chng; Lay Leng Seah; Morgan Yang; Sunny Yu Shen; Siew Kwan Koh; Yan Gao; Lu Deng; Louis Tong; Roger Wilmer Beuerman; Lei Zhou
Journal:  Sci Rep       Date:  2018-11-16       Impact factor: 4.379

5.  Tear proteomics of orbital decompression for disfiguring exophthalmos in inactive thyroid-associated ophthalmopathy.

Authors:  Lihong Jiang; Ao Rong; Ruili Wei; Jiale Diao; Hui Ding; Wei Wang
Journal:  Exp Ther Med       Date:  2020-10-23       Impact factor: 2.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.